1. Market Research
  2. > Biopharmaceutical Industry

Growth Hormone Industry, December 2016 Market Reports from Top Publishers

You might be interested in: Diagnostics, In Vitro Diagnostic Reagent, Biosimilar, Therapy, Protein, Biopharmaceutical, Herbicide, Injectable Delivery, Human Growth Hormone, Agrochemical, Biotherapy, Hormones, Pharmaceutical, Insulin, Meat, Monoclonal Antibody, Protein Engineering.


 
1-10 of 33 reports for Growth Hormone

Purchase Reports From Reputable Market Research Publishers

Growth Hormone (GH) Agonists -Pipeline Insights, 2016

Growth Hormone (GH) Agonists -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Growth Hormone (GH) Agonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone (GH) Agonists. ...

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2000
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Report, “Growth Hormone Deficiency-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Growth Hormone Antagonists -Pipeline Insights, 2016

Growth Hormone Antagonists -Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “Growth Hormone Antagonists-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Antagonists. ...

 Growth Hormone Deficiency-Pipeline Insights, 2016

Growth Hormone Deficiency-Pipeline Insights, 2016

  • $ 1250
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s, “ Growth Hormone Deficiency-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Growth Hormone Deficiency. ...

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

Growth Hormone Deficiency (GHD)  - Market Insights, Epidemiology and Market Forecast-2023

  • $ 4950
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight’s Growth Hormone Deficiency (GHD) - Market Insights, Epidemiology and Market Forecast-2023” Reports provides an overview of the disease and global market trends of the Growth Hormone Deficiency ...

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023

  • $ 2750
  • Industry report
  • November 2016
  • by Delve Insight

DelveInsight “Growth Hormone Deficiency (GHD)  - Epidemiology Forecast To 2023” provides an overview of the epidemiology trends of Growth Hormone Deficiency (GHD)  in seven major markets (US, France, ...

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • September 2016
  • by Global Markets Direct

Growth Hormone Secretagogue Receptor Type 1 (GH Releasing Peptide Receptor or Ghrelin Receptor or GHSR) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Growth Hormone Secretagogue Recepto ...

Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

Medical Affairs Reputations: Growth Hormone Deficiency (EU5)

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Can Medical Affairs teams from branded players maintain dominance over biosimilars? Two medical affairs teams lead in the EU5 growth hormone deficiency (GHD) treatment market, but for how long? Competition ...

Medical Affairs Reputations: Growth Hormone Deficiency (US)

Medical Affairs Reputations: Growth Hormone Deficiency (US)

  • $ 5390
  • Industry report
  • September 2016
  • by Firstword Pharma

Two Medical Affairs teams lead the market. Can your team learn from their success? Two medical affairs teams have the lead in the US growth hormone deficiency (GHD) treatment market, with the third placed ...

NPS+ Growth Hormone Deficiency (GHD)  (EU5)

NPS+ Growth Hormone Deficiency (GHD) (EU5)

  • $ 2668
  • Industry report
  • July 2016
  • by Firstword Pharma

Just one brand shows a positive Net Promoter Score in the EU: fertile ground for other brands to gain share? EU endocrinologists are not overly satisfied with current growth hormone deficiency treatment ...

About 3100 reports for Growth Hormone

Download Unlimited Documents from Trusted Public Sources

Salmon Industry in the US

  • November 2015
    161 pages
  • Salmon  

    Fish  

    Food  

  • United States  

View report >

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.